The sympathetic nervous response in inflammation

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Pongratz, Georg ^a   Straub, Rainer H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE;

ADRENERGIC SYSTEM; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; AUTOIMMUNITY; CACHEXIA; CARDIOVASCULAR MORTALITY; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; NONHUMAN; REVIEW; SYMPATHETIC FUNCTION; SYMPATHETIC NERVOUS RESPONSE; SYNOVITIS; SYSTEMATIC REVIEW;

EID: 84924294664     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0504-2     Document Type: Review

References (104)

1. Meltzer SJ, Meltzer C: On a difference in the influence upon inflammation between the section of the sympathetic nerve and the removal of the sympathetic ganglion. J Med Res 1903, 10:135-141.
2. Hopkin DA, Laplane R: James Reilly and the autonomic nervous system. A prophet unheeded? Ann R Coll Surg Engl 1978, 60:108-116.
3. Besedovsky H, del Rey A, Sorkin E, Dinarello CA: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986, 233:652-654.
4. Nance DM, Sanders VM: Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 2007, 21:736-745.
5. Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, Maier SF, Watkins LR: Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull 1997, 43:357-364.
6. Zielinski MR, Dunbrasky DL, Taishi P, Souza G, Krueger JM: Vagotomy attenuates brain cytokines and sleep induced by peripherally administered tumor necrosis factor-alpha and lipopolysaccharide in mice. Sleep 2013, 36:227-1238. 1238A.
7. Pöyhönen-Alho MK, Manhem K, Katzman P, Kibarskis A, Antikainen RL, Erkkola RU, Tuomilehto JO, Ebeling PE, Kaaja RJ: Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. J Hypertens 2008, 26:2445-2449.
8. Bernstein IM, Damron D, Schonberg AL, Shapiro R: The relationship of plasma volume, sympathetic tone, and proinflammatory cytokines in young healthy nonpregnant women. Reprod Sci 2009, 16:980-985.
9. Straub RH, Kalden JR: Stress of different types increases the proinflammatory load in rheumatoid arthritis. Arthritis Res Ther 2009, 11:114.
10. del Rey A, Wolff C, Wildmann J, Randolf A, Hahnel A, Besedovsky HO, Straub RH: Disrupted brain-immune system-joint communication during experimental arthritis. Arthritis Rheum 2008, 58:3090-3099.
11. Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowki JA, Livnat S: Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev 1987, 100:225-260.
12. Carr DJJ, Blalock JE: Neuropeptide hormones and receptors common to the immune and neuroendocrine systems: bidirectional pathway of intersystem communication. In Psychoneuroimmunology. 2nd edition. Edited by Ader R, Felten DL, Cohen N. San Diego: Academic Press, Inc. 1991:573-588.
13. Thompson M, Bywaters EG: Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 1962, 21:370-377.
14. Tarkowski E, Naver H, Wallin BG, Blomstrand C, Tarkowski A: Lateralization of T-lymphocyte responses in patients with stroke. Effect of sympathetic dysfunction? Stroke 1995, 26:57-62.
15. Tarkowski E, Naver H, Wallin BG, Blomstrand C, Grimby G, Tarkowski A: Lateralization of cutaneous inflammatory responses in patients with unilateral paresis after poliomyelitis. J Neuroimmunol 1996, 67:1-6.
16. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003, 198:725-736.
17. Straub RH, Pongratz G, Weidler C, Linde HJ, Kirschning CJ, Glück T, Schölmerich J, Falk W: Ablation of the sympathetic nervous system decreases gram-negative and increases gram-positive bacterial dissemination: key roles for tumor necrosis factor/phagocytes and interleukin-4/lymphocytes. J Infect Dis 2005, 192:560-572.
18. Burnstock G: Cotransmission in the autonomic nervous system. Handb Clin Neurol 2013, 117:23-35.
19. Sung CP, Arleth AJ, Feuerstein GZ: Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. Circ Res 1991, 68:314-318.
20. Claxson A, Morris C, Blake D, Sirén M, Halliwell B, Gustafsson T, Löfkvist B, Bergelin I: The anti-inflammatory effects of D-myo-inositol-1.2.6-trisphosphate (PP56) on animal models of inflammation. Agents Actions 1990, 29:68-70.
21. Howarth D, Burstal R, Hayes C, Lan L, Lantry G: Autonomic regulation of lymphatic flow in the lower extremity demonstrated on lymphoscintigraphy in patients with reflex sympathetic dystrophy. Clin Nucl Med 1999, 24:383-387.
22. Scheiermann C, Kunisaki Y, Lucas D, Chow A, Jang JE, Zhang D, Hashimoto D, Merad M, Frenette PS: Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity 2012, 37:290-301.
23. Powell ND, Sloan EK, Bailey MT, Arevalo JM, Miller GE, Chen E, Kobor MS, Reader BF, Sheridan JF, Cole SW: Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via beta-adrenergic induction of myelopoiesis. Proc Natl Acad Sci U S A 2013, 110:16574-16579.
24. Merhi M, Helme RD, Khalil Z: Age-related changes in sympathetic modulation of sensory nerve activity in rat skin. Inflamm Res 1998, 47:239-244.
25. Dawson LF, Phillips JK, Finch PM, Inglis JJ, Drummond PD: Expression of alpha1-adrenoceptors on peripheral nociceptive neurons. Neuroscience 2011, 175:300-314.
26. Seeley EJ, Barry SS, Narala S, Matthay MA, Wolters PJ: Noradrenergic neurons regulate monocyte trafficking and mortality during gram-negative peritonitis in mice. J Immunol 2013, 190:4717-4724.
27. Drummond PD: The effect of sympathetic activity on thermal hyperalgesia in capsaicin-treated skin during body cooling and warming. Eur J Pain 2001, 5:59-67.
28. Birklein F, Kunzel W, Sieweke N: Despite clinical similarities there are significant differences between acute limb trauma and complex regional pain syndrome I (CRPS I). Pain 2001, 93:165-171.
29. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL: Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 1990, 145:1430-1434.
30. Severn A, Rapson NT, Hunter CA, Liew FY: Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 1992, 148:3441-3445.
31. Szabó C, Haskó G, Zingarelli B, Németh ZH, Salzman AL, Kvetan V, Pastores SM, Vizi ES: Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 1997, 90:95-100.
32. Xiu F, Stanojcic M, Jeschke MG: Norepinephrine inhibits macrophage migration by decreasing CCR2 expression. PLoS One 2013, 8:e69167.
33. Szelenyi J, Kiss JP, Vizi ES: Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. J Neuroimmunol 2000, 103:34-40.
34. Zhou JR, Zhang LD, Wei HF, Wang X, Ni HL, Yang F, Zhang T, Jiang CL: Neuropeptide Y induces secretion of high-mobility group box 1 protein in mouse macrophage via PKC/ERK dependent pathway. J Neuroimmunol 2013, 260:55-59.
35. Manni M, Granstein RD, Maestroni G: beta2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response. Cytokine 2011, 55:380-386.
36. Yanagawa Y, Matsumoto M, Togashi H: Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells. Brain Behav Immun 2011, 25:1427-1433.
37. Yanagawa Y, Matsumoto M, Togashi H: Enhanced dendritic cell antigen uptake via alpha2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J Immunol 2010, 185:5762-5768.
38. Goyarts E, Matsui M, Mammone T, Bender AM, Wagner JA, Maes D, Granstein RD: Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp Dermatol 2008, 17:188-196.
39. Wirth T, Westendorf AM, Bloemker D, Wildmann J, Engler H, Mollerus S, Wadwa M, Schäfer MK, Schedlowski M, del Rey A: The sympathetic nervous system modulates CD4Foxp3 regulatory T cells via noradrenaline-dependent apoptosis in a murine model of lymphoproliferative disease. Brain Behav Immun 2014, 38:100-110.
40. Guereschi MG, Araujo LP, Maricato JT, Takenaka MC, Nascimento VM, Vivanco BC, Reis VO, Keller AC, Brum PC, Basso AS: Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner. Eur J Immunol 2013, 43:1001-1012.
41. Straub RH, Rauch L, Fassold A, Lowin T, Pongratz G: Neuronally released sympathetic neurotransmitters stimulate splenic interferon-gamma secretion from T cells in early type II collagen-induced arthritis. Arthritis Rheum 2008, 58:3450-3460.
42. Ramer-Quinn DS, Swanson MA, Lee WT, Sanders VM: Cytokine production by naive and primary effector CD4+ T cells exposed to norepinephrine. Brain Behav Immun 2000, 14:239-255.
43. Swanson MA, Lee WT, Sanders VM: IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. J Immunol 2001, 166:232-240.
44. Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H: Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 1998, 5:9-15.
45. Pongratz G, Melzer M, Straub RH: The sympathetic nervous system stimulates anti-inflammatory B cells in collagen-type II-induced arthritis. Ann Rheum Dis 2012, 71:432-439.
46. Pongratz G, Anthofer JM, Melzer M, Anders S, Grassel S, Straub RH: IL-7 receptor alpha expressing B cells act proinflammatory in collagen-induced arthritis and are inhibited by sympathetic neurotransmitters. Ann Rheum Dis 2014, 73:306-312.
47. Pongratz G, McAlees JW, Conrad DH, Erbe RS, Haas KM, Sanders VM: The level of IgE produced by a B cell is regulated by norepinephrine in a p38. J Immunol 2006, 177:2926-2938.
48. Podojil JR, Sanders VM: Selective regulation of mature IgG1 transcription by CD86 and beta 2-adrenergic receptor stimulation. J Immunol 2003, 170:5143-5151.
49. Prösch S, Wendt CE, Reinke P, Priemer C, Oppert M, Krüger DH, Volk HD, Döcke WD: A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology 2000, 272:357-365.
50. Swain MG, Blennerhassett PA, Collins SM: Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterology 1991, 100:675-682.
51. Harle P, Mobius D, Carr DJ, Scholmerich J, Straub RH: An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum 2005, 52:1305-1313.
52. Li W, Knowlton D, Woodward WR, Habecker BA: Regulation of noradrenergic function by inflammatory cytokines and depolarization. J Neurochem 2003, 86:774-783.
53. Lorton D, Lubahn C, Bellinger DL: Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr Drug Targets Inflamm Allergy 2003, 2:1-30.
54. Donoso V, Gomez CR, Orriantia MA, Pérez V, Torres C, Coddou C, Nelson P, Maisey K, Morales B, Fernandez R, Imarai M, Huidobro-Toro JP, Sierra F, Acuña-Castillo C: The release of sympathetic neurotransmitters is impaired in aged rats after an inflammatory stimulus: a possible link between cytokine production and sympathetic transmission. Mech Ageing Dev 2008, 129:728-734.
55. Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ: Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev 2012, 248:188-204.
56. Bratton BO, Martelli D, McKinley MJ, Trevaks D, Anderson CR, McAllen RM: Neural regulation of inflammation: no neural connection from the vagus to splenic sympathetic neurons. Exp Physiol 2012, 97:1180-1185.
57. Martelli D, McKinley MJ, McAllen RM: The cholinergic anti-inflammatory pathway: A critical review. Auton Neurosci 2013, 182:65-69.
58. Martelli D, Yao ST, McKinley MJ, McAllen RM: Reflex control of inflammation by sympathetic nerves, not the vagus. J Physiol 2014, 592:1677-1686.
59. Todorov LD, Mihaylova-Todorova ST, Bjur RA, Westfall DP: Differential cotransmission in sympathetic nerves: role of frequency of stimulation and prejunctional autoreceptors. J Pharmacol Exp Ther 1999, 290:241-246.
60. Stohl LL, Zang JB, Ding W, Manni M, Zhou XK, Granstein RD: Norepinephrine and adenosine-5'-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells. Cytokine 2013, 64:605-612.
61. Chen E, Miller GE: Stress and inflammation in exacerbations of asthma. Brain Behav Immun 2007, 21:993-999.
62. Saunders PR, Miceli P, Vallance BA, Wang L, Pinto S, Tougas G, Kamath M, Jacobson K: Noradrenergic and cholinergic neural pathways mediate stress-induced reactivation of colitis in the rat. Auton Neurosci 2006, 124:56-68.
63. Straub RH, Grum F, Strauch U, Capellino S, Bataille F, Bleich A, Falk W, Schölmerich J, Obermeier F: Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Gut 2008, 57:911-921.
64. Steinle JJ: Sympathetic neurotransmission modulates expression of inflammatory markers in the rat retina. Exp Eye Res 2007, 84:118-125.
65. Lorton D, Lubahn C, Klein N, Schaller J, Bellinger DL: Dual role for noradrenergic innervation of lymphoid tissue and arthritic joints in adjuvant-induced arthritis. Brain Behav Immun 1999, 13:315-334.
66. Arnold J, de Arellano ML B, Rüster C, Vercellino GF, Chiantera V, Schneider A, Mechsner S: Imbalance between sympathetic and sensory innervation in peritoneal endometriosis. Brain Behav Immun 2012, 26:132-141.
67. Manni M, Maestroni GJ: Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: involvement of beta-adrenoceptors and relevance in inflammatory diseases. Brain Behav Immun 2008, 22:80-88.
68. Grebe KM, Takeda K, Hickman HD, Bailey AL, Embry AC, Bennink JR, Yewdell JW: Cutting edge: Sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis. J Immunol 2010, 184:540-544.
69. Machado MP, Rocha AM, de Oliveira LF, de Cuba MB, de Oliveira LI, Castellano LR, Silva MV, Machado JR, Nascentes GA, Paiva LH, Savino W, Junior VR, Brum PC, Prado VF, Prado MA, Silva EL, Montano N, Ramirez LE, VJ D d S: Autonomic nervous system modulation affects the inflammatory immune response in mice with acute Chagas disease. Exp Physiol 2012, 97:1186-1202.
70. Schlereth T, Drummond PD, Birklein F: Inflammation in CRPS: role of the sympathetic supply. Auton Neurosci 2013, 182:102-107.
71. Levick SP, Murray DB, Janicki JS, Brower GL: Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension 2010, 55:270-276.
72. Strack I, Schulte S, Varnholt H, Schievenbusch S, Töx U, Wendland K, Steffen HM, Drebber U, Dienes HP, Odenthal M: beta-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis. Lab Invest 2011, 91:252-261.
73. Hermann G, Beck FM, Tovar CA, Malarkey WB, Allen C, Sheridan JF: Stress-induced changes attributable to the sympathetic nervous system during experimental influenza viral infection in DBA/2 inbred mouse strain. J Neuroimmunol 1994, 53:173-180.
74. Fitzgerald PJ: Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint. Clin Epidemiol 2012, 4:151-156.
75. Oberbeck R, Schmitz D, Wilsenack K, Schüler M, Pehle B, Schedlowski M, Exton MS: Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation 2004, 11:214-223.
76. Zhou M, Hank SH, Wang P: Increased gut-derived norepinephrine release in sepsis: up-regulation of intestinal tyrosine hydroxylase. Biochim Biophys Acta 2004, 1689:212-218.
77. Kidd BL, Cruwys S, Mapp PI, Blake DR: Role of the sympathetic nervous system in chronic joint pain and inflammation. Ann Rheum Dis 1992, 51:1188-1191.
78. Levine JD, Fye K, Heller P, Basbaum AI, Whiting-O'Keefe Q: Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis. J Rheumatol 1986, 13:1040-1043.
79. Aloe L, Tuveri MA, Levi-Montalcini R: Studies on carrageenan-induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation. Rheumatol Int 1992, 12:213-216.
80. Levine JD, Moskowitz MA, Basbaum AI: The contribution of neurogenic inflammation in experimental arthritis. J Immunol 1985, 135:843s-847s.
81. Levine JD, Dardick SJ, Roizen MF, Helms C, Basbaum AI: Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986, 6:3423-3429.
82. Ebbinghaus M, Gajda M, Boettger MK, Schaible HG, Brauer R: The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis 2012, 71:253-261.
83. Harle P, Pongratz G, Albrecht J, Tarner IH, Straub RH: An early sympathetic nervous system influence exacerbates collagen-induced arthritis via CD4 + CD25+ cells. Arthritis Rheum 2008, 58:2347-2355.
84. Mapp PI, Walsh DA, Garrett NE, Kidd BL, Cruwys SC, Polak JM, Blake DR: Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis 1994, 53:240-246.
85. Miller LE, Justen HP, Scholmerich J, Straub RH: The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000, 14:2097-2107.
86. Fassold A, Falk W, Anders S, Hirsch T, Mirsky VM, Straub RH: Soluble neuropilin-2, a nerve repellent receptor, is increased in rheumatoid arthritis synovium and aggravates sympathetic fiber repulsion and arthritis. Arthritis Rheum 2009, 60:2892-2901.
87. Capellino S, Weber K, Gelder M, Harle P, Straub RH: First appearance and location of catecholaminergic cells during experimental arthritis and elimination by chemical sympathectomy. Arthritis Rheum 2012, 64:1110-1118.
88. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, Gao H, Van Rooijen N, Huber-Lang MS, Neubig RR, Ward PA: Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007, 449:721-725.
89. Cosentino M, Fietta AM, Ferrari M, Rasini E, Bombelli R, Carcano E, Saporiti F, Meloni F, Marino F, Lecchini S: Human CD4 + CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 2007, 109:632-642.
90. Capellino S, Cosentino M, Wolff C, Schmidt M, Grifka J, Straub RH: Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. Ann Rheum Dis 2010, 69:1853-1860.
91. Jenei-Lanzl Z, Capellino S, Kees F, Fleck M, Lowin T, Straub RH: Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritis. Ann Rheum Dis 2013, doi:10.1136/annrheumdis-2013-203925.
92. Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E: Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007, 204:1303-1310.
93. Straub RH, Cutolo M, Buttgereit F, Pongratz G: Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med 2010, 267:543-560.
94. Lo EJ, Green PG, Miao FJ, Relchling DB, Levine JD: Bradykinin-induced neurogenic migration of neutrophils into the rat knee joint. Neuroreport 1999, 10:3821-3824.
95. Sanders VM: The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? Brain Behav Immun 2012, 26:195-200.
96. Grailer JJ, Haggadone MD, Sarma JV, Zetoune FS, Ward PA: Induction of M2 regulatory macrophages through the beta-adrenergic receptor with protection during endotoxemia and acute lung injury. J Innate Immun 2014, 6:607-618.
97. Stanojevic S, Dimitrijevic M, Kustrimovic N, Mitic K, Vujic V, Leposavic G: Adrenal hormone deprivation affects macrophage catecholamine metabolism and beta2-adrenoceptor density, but not propranolol stimulation of tumour necrosis factor-alpha production. Exp Physiol 2013, 98:665-678.
98. Deo SH, Jenkins NT, Padilla J, Parrish AR, Fadel PJ: Norepinephrine increases NADPH oxidase-derived superoxide in human peripheral blood mononuclear cells via alpha-adrenergic receptors. Am J Physiol Regul Integr Comp Physiol 2013, 305:R1124-R1132.
99. Buxton IL, Brunton LL: Alpha-adrenergic receptors on rat ventricular myocytes: characteristics and linkage to cAMP metabolism. Am J Physiol 1986, 251:H307-H313.
100. Vega JL, Keino H, Masli S: Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege. Am J Pathol 2009, 175:1218-1225.
101. Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ: Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 2004, 22:63-70.
102. Straub RH: Evolutionary medicine and chronic inflammatory state - known and new concepts in pathophysiology. J Mol Med (Berl) 2012, 90:523-534.
103. Poole RM, Ballantyne AD: Apremilast: first global approval. Drugs 2014, 74:825-837.
104. Schafer P: Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol 2012, 83:1583-1590.